扁平苔癬の世界市場レポート 2025年

扁平苔癬の市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR7.1％で16億6,000万米ドルに成長します。予測期間の成長は、生物学的療法に対する需要の増加、新たな治療オプションの継続的な臨床研究、遠隔皮膚科サービスの拡大、個別化医療の重視、新興地域におけるヘルスケアインフラの開発などに起因すると考えられます。この期間に予想される主な動向には、標的生物学的製剤の進歩、皮膚科診断における人工知能の応用、革新的ドラッグデリバリーシステム、遠隔医療プラットフォームの採用、皮膚モニタリング用ウェアラブルデバイス、3D皮膚画像技術の利用などがあります。

自己免疫疾患の増加は、今後数年間の扁平苔癬市場の成長を促進すると予想されます。自己免疫疾患は、免疫系が誤って体内の健康な組織を攻撃することで発生します。これらの疾患には、関節リウマチ、全身性エリテマトーデス、1型糖尿病、多発性硬化症、乾癬などが含まれます。自己免疫疾患の増加は、特定の遺伝子の変異が免疫系機能に影響を与える遺伝的素因や、結合組織の異常の影響を受けています。このような自己免疫疾患の増加は、免疫系の調節不全という広範な問題を反映しており、扁平苔癬の症例数の増加につながっています。例えば、2024年6月、オーストラリアの政府機関であるAustralian Institute of Health and Welfareは、2022年には人口の2％にあたる約51万4,000人が関節リウマチに罹患していると報告しました。この疾患は、2023年には全疾患負担の2％、筋骨格系疾患負担の16％を占め、2022年には関連死1,322人、人口10万人当たり5.1人の死亡が記録され、全死亡の0.7％に相当します。したがって、自己免疫疾患の有病率の上昇は、扁平苔癬市場の成長を促進する主な要因です。

扁平苔癬市場の主要企業は、標的ドラッグデリバリーを改善し、全身的副作用を軽減するために、リポソーム製剤のような革新的アプローチの開発に注力しています。リポソーム製剤は、脂質二重膜からなる小さな球状の小胞であるリポソームに有効成分を封入した先進的なドラッグデリバリーシステムです。これらの製剤は、薬物の安定性を高め、吸収を改善し、患部への正確な送達を可能にする一方で、体内の他の部分への曝露を最小限に抑えるのに役立ちます。例えば、2025年2月、米国に本社を置き、重篤な疾患の治療薬に特化したバイオテクノロジー企業であるLipella Pharmaceuticals Inc.は、米国食品医薬品局からLP310の拡大アクセスプログラムの承認を取得しました。本製品はタクロリムスのリポソーム製剤であり、経口扁平苔癬を有する患者に対し、全身への曝露を制限しつつ、標的を絞った緩和を提供するために創製されました。このプログラムにより、代替治療法のない重篤な疾患や生命を脅かす疾患を有する患者が、承認前の臨床試験以外の治療法にアクセスできるようになります。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の扁平苔癬のPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の扁平苔癬市場：成長率分析
• 世界の扁平苔癬市場の実績：規模と成長、2019～2024年
• 世界の扁平苔癬市場の予測：規模と成長、2024～2029年、2034年
• 世界の扁平苔癬総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の扁平苔癬市場：疾患タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 扁平苔癬
• 口腔扁平苔癬
• 性器扁平苔癬
• 色素性扁平苔癬
• 世界の扁平苔癬市場：治療タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 局所療法
• 全身療法
• 光線療法
• 代替治療
• 世界の扁平苔癬市場：投与経路別、実績と予測、2019～2024年、2024～2029年、2034年
• 局所
• 経口
• 静脈内
• 皮内
• 世界の扁平苔癬市場：エンドユーザー別、実績と予測、2019～2024年、2024～2029年、2034年
• 病院
• ホームケア
• 専門クリニック
• その他
• 世界の扁平苔癬市場：扁平苔癬のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 丘疹扁平苔癬
• 肥厚性扁平苔癬
• 光線性扁平苔癬
• 線状扁平苔癬
• 環状扁平苔癬
• 世界の扁平苔癬市場：口腔扁平苔癬のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 網状口腔扁平苔癬
• 口腔びらん性扁平苔癬
• 萎縮性口腔扁平苔癬
• プラーク様口腔扁平苔癬
• 水疱性口腔扁平苔癬
• 世界の扁平苔癬市場：性器扁平苔癬のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• びらん性性器扁平苔癬
• 丘疹性性器扁平苔癬
• 環状生殖器扁平苔癬
• 外陰膣歯肉症候群
• 世界の扁平苔癬市場：色素性扁平苔癬のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• びまん性色素性扁平苔癬
• 斑状色素性扁平苔癬
• 線状色素性扁平苔癬
• 毛包周囲色素性扁平苔癬
• 屈曲性色素性扁平苔癬

第7章 地域別・国別分析

• 世界の扁平苔癬市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界の扁平苔癬市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 扁平苔癬市場：競合情勢
• 扁平苔癬市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
  • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Inc Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Sanofi SA
• Bristol-Myers Squibb Company
• AstraZeneca plc
• Novartis AG
• GlaxoSmithKline plc
• Takeda Pharmaceutical Company
• Eli Lilly and Company
• Teva Pharmaceutical Industries Ltd.
• Boehringer Ingelheim International GmbH
• Dr. Reddy's Laboratories Ltd
• Amneal Pharmaceuticals Inc.
• Hikma Pharmaceuticals plc
• LEO Pharma A/S
• Basilea Pharmaceutica Ltd.
• UCB S.A.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 扁平苔癬市場2029年：新たな機会を提供する国
• 扁平苔癬市場2029年：新たな機会を提供するセグメント
• 扁平苔癬市場2029年：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Lichen planus is a persistent inflammatory condition that targets the skin, mucous membranes, and occasionally the nails or hair. It is marked by the appearance of purplish, itchy, flat-topped lesions, typically seen on the wrists, ankles, and lower back. The condition can also impact the inside of the mouth, leading to white, lace-including patches or painful ulcers.

The primary forms of the disease include lichen planus, oral lichen planus, genital lichen planus, and lichen planus pigmentosus. It is a chronic autoimmune disorder in which the immune system erroneously attacks the skin and mucous membranes. Treatment options encompass topical therapies, systemic therapies, phototherapy, and alternative approaches. These therapies are administered through various routes, including topical, oral, intravenous, and intradermal methods, and are used across healthcare settings such as hospitals, homecare, specialty clinics, and other facilities.

The lichen planus market research report is one of a series of new reports from The Business Research Company that provides lichen planus market statistics, including lichen planus industry global market size, regional shares, competitors with a lichen planus market share, detailed lichen planus market segments, market trends and opportunities, and any further data you may need to thrive in the lichen planus industry. The lichen planus market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The lichen planus market size has grown strongly in recent years. It will grow from $1.18 billion in 2024 to $1.27 billion in 2025 at a compound annual growth rate (CAGR) of 7.3%. The growth during the historic period can be credited to increased awareness of skin-related conditions, enhanced access to medical care, a rising elderly population, the proliferation of dermatology clinics, and higher healthcare expenditures.

The lichen planus market size is expected to see strong growth in the next few years. It will grow to $1.66 billion in 2029 at a compound annual growth rate (CAGR) of 7.1%. The projected growth in the forecast period can be attributed to increasing demand for biologic therapies, continuous clinical research into new treatment options, the expansion of teledermatology services, a heightened emphasis on personalized medicine, and the development of healthcare infrastructure in emerging regions. Key trends expected during this period include advancements in targeted biologics, the application of artificial intelligence in dermatological diagnostics, innovative drug delivery systems, the adoption of telemedicine platforms, wearable devices for skin monitoring, and the use of 3D skin imaging technologies.

The increasing prevalence of autoimmune diseases is expected to drive the growth of the lichen planus market in the coming years. Autoimmune diseases occur when the immune system mistakenly attacks the body's own healthy tissues. These conditions include rheumatoid arthritis, lupus, type 1 diabetes, multiple sclerosis, and psoriasis. The rise in autoimmune diseases is influenced by genetic predisposition, where specific gene variations affect immune system function, as well as abnormalities in connective tissues. This growing occurrence of autoimmune disorders reflects a broader issue of immune system dysregulation and is linked to a higher number of lichen planus cases. For example, in June 2024, the Australian Institute of Health and Welfare, a government agency in Australia, reported that approximately 514,000 people or 2 percent of the population were living with rheumatoid arthritis in 2022. This condition accounted for 2 percent of the total disease burden and 16 percent of the musculoskeletal conditions burden in 2023, with 1,322 related deaths or 5.1 deaths per 100,000 people recorded in 2022, representing 0.7 percent of all deaths. Therefore, the rising prevalence of autoimmune diseases is a major factor fueling the growth of the lichen planus market.

Leading companies in the lichen planus market are focusing on the development of innovative approaches such as liposomal formulations to improve targeted drug delivery and reduce systemic side effects. Liposomal formulations are advanced drug delivery systems in which active ingredients are enclosed within liposomes, which are small spherical vesicles composed of lipid bilayers. These formulations help enhance drug stability, improve absorption, and allow for precise delivery to affected areas while minimizing exposure to the rest of the body. For example, in February 2025, Lipella Pharmaceuticals Inc., a biotechnology company based in the United States that focuses on treatments for serious diseases, received approval from the United States Food and Drug Administration for an expanded access program for LP 310. This product is a liposomal formulation of tacrolimus, created to deliver targeted relief to patients with oral lichen planus while limiting systemic exposure. The program enables patients with serious or life threatening conditions who lack alternative treatment options to access therapies outside of clinical trials prior to full regulatory approval.

In September 2024, Eli Lilly and Company, a U.S.-based pharmaceutical company, formed a partnership with EVA Pharma to improve access to baricitinib (Olumiant) in 49 low- to middle-income countries across Africa. This collaboration aims to reach approximately 20,000 patients by 2030, targeting conditions such as lichen planus, rheumatoid arthritis, alopecia areata, and atopic dermatitis. Under the agreement, Lilly will provide manufacturing expertise to help EVA Pharma locally produce and distribute the medication. EVA Pharma is an Egypt-based pharmaceutical company, specializing in the production and distribution of generic prescription medications across a wide range of therapeutic areas.

Major players in the lichen planus market are Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc, AbbVie Inc., Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca plc, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim International GmbH, Dr. Reddy's Laboratories Ltd, Amneal Pharmaceuticals Inc., Hikma Pharmaceuticals plc, LEO Pharma A/S, Basilea Pharmaceutica Ltd., UCB S.A., Almirall SA, and Lipella Pharmaceuticals Inc.

North America was the largest region in the lichen planus market in 2024. The regions covered in lichen planus report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the lichen planus market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The lichen planus market consists of revenues earned by entities by providing services such as narrowband UVB therapy, oral hygiene counseling, and dental check-ups. The market value includes the value of related goods sold by the service provider or included within the service offering. The lichen planus market also includes sales of topical corticosteroids, systemic immunosuppressants, antihistamines, biologic therapies, phototherapy equipment, diagnostic tools, and herbal and alternative remedies. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Lichen Planus Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on lichen planus market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for lichen planus ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The lichen planus market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Disease Type: Lichen Planus; Oral Lichen Planus; Genital Lichen Planus; Lichen Planus Pigmentosus
• 2) By Treatment Type: Topical Therapies; Systemic Therapies; Phototherapy; Alternative Treatment
• 3) By Route Of Administration: Topical; Oral; Intravenous; Intradermal
• 4) By End User: Hospitals; Homecare; Specialty Clinics; Other End-Users
• Subsegments:
• 1) By Lichen Planus: Papular Lichen Planus; Hypertrophic Lichen Planus; Actinic Lichen Planus; Linear Lichen Planus; Annular Lichen Planus
• 2) By Oral Lichen Planus: Reticular Oral Lichen Planus; Erosive Oral Lichen Planus; Atrophic Oral Lichen Planus; Plaque-Like Oral Lichen Planus; Bullous Oral Lichen Planus
• 3) By Genital Lichen Planus: Erosive Genital Lichen Planus; Papular Genital Lichen Planus; Annular Genital Lichen Planus; Vulvovaginal-Gingival Syndrome
• 4) By Lichen Planus Pigmentosus: Diffuse Lichen Planus Pigmentosus; Blotchy Lichen Planus Pigmentosus; Linear Lichen Planus Pigmentosus; Perifollicular Lichen Planus Pigmentosus; Flexural Lichen Planus Pigmentosus
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson Services Inc.; F. Hoffmann-La Roche AG; Merck & Co. Inc; AbbVie Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Lichen Planus Market Characteristics

3. Lichen Planus Market Trends And Strategies

4. Lichen Planus Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Lichen Planus Growth Analysis And Strategic Analysis Framework

• 5.1. Global Lichen Planus PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Lichen Planus Market Growth Rate Analysis
• 5.4. Global Lichen Planus Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Lichen Planus Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Lichen Planus Total Addressable Market (TAM)

6. Lichen Planus Market Segmentation

• 6.1. Global Lichen Planus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Lichen Planus
• Oral Lichen Planus
• Genital Lichen Planus
• Lichen Planus Pigmentosus
• 6.2. Global Lichen Planus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Topical Therapies
• Systemic Therapies
• Phototherapy
• Alternative Treatment
• 6.3. Global Lichen Planus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Topical
• Oral
• Intravenous
• Intradermal
• 6.4. Global Lichen Planus Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Homecare
• Specialty Clinics
• Other End-Users
• 6.5. Global Lichen Planus Market, Sub-Segmentation Of Lichen Planus, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Papular Lichen Planus
• Hypertrophic Lichen Planus
• Actinic Lichen Planus
• Linear Lichen Planus
• Annular Lichen Planus
• 6.6. Global Lichen Planus Market, Sub-Segmentation Of Oral Lichen Planus, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Reticular Oral Lichen Planus
• Erosive Oral Lichen Planus
• Atrophic Oral Lichen Planus
• Plaque-Like Oral Lichen Planus
• Bullous Oral Lichen Planus
• 6.7. Global Lichen Planus Market, Sub-Segmentation Of Genital Lichen Planus, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Erosive Genital Lichen Planus
• Papular Genital Lichen Planus
• Annular Genital Lichen Planus
• Vulvovaginal-Gingival Syndrome
• 6.8. Global Lichen Planus Market, Sub-Segmentation Of Lichen Planus Pigmentosus, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diffuse Lichen Planus Pigmentosus
• Blotchy Lichen Planus Pigmentosus
• Linear Lichen Planus Pigmentosus
• Perifollicular Lichen Planus Pigmentosus
• Flexural Lichen Planus Pigmentosus

7. Lichen Planus Market Regional And Country Analysis

• 7.1. Global Lichen Planus Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Lichen Planus Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Lichen Planus Market

• 8.1. Asia-Pacific Lichen Planus Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Lichen Planus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Lichen Planus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Lichen Planus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Lichen Planus Market

• 9.1. China Lichen Planus Market Overview
• 9.2. China Lichen Planus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Lichen Planus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Lichen Planus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Lichen Planus Market

• 10.1. India Lichen Planus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Lichen Planus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Lichen Planus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Lichen Planus Market

• 11.1. Japan Lichen Planus Market Overview
• 11.2. Japan Lichen Planus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Lichen Planus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Lichen Planus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Lichen Planus Market

• 12.1. Australia Lichen Planus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Lichen Planus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Lichen Planus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Lichen Planus Market

• 13.1. Indonesia Lichen Planus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Lichen Planus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Lichen Planus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Lichen Planus Market

• 14.1. South Korea Lichen Planus Market Overview
• 14.2. South Korea Lichen Planus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Lichen Planus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Lichen Planus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Lichen Planus Market

• 15.1. Western Europe Lichen Planus Market Overview
• 15.2. Western Europe Lichen Planus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Lichen Planus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Lichen Planus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Lichen Planus Market

• 16.1. UK Lichen Planus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Lichen Planus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Lichen Planus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Lichen Planus Market

• 17.1. Germany Lichen Planus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Lichen Planus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Lichen Planus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Lichen Planus Market

• 18.1. France Lichen Planus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Lichen Planus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Lichen Planus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Lichen Planus Market

• 19.1. Italy Lichen Planus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Lichen Planus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Lichen Planus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Lichen Planus Market

• 20.1. Spain Lichen Planus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Lichen Planus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Lichen Planus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Lichen Planus Market

• 21.1. Eastern Europe Lichen Planus Market Overview
• 21.2. Eastern Europe Lichen Planus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Lichen Planus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Lichen Planus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Lichen Planus Market

• 22.1. Russia Lichen Planus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Lichen Planus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Lichen Planus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Lichen Planus Market

• 23.1. North America Lichen Planus Market Overview
• 23.2. North America Lichen Planus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Lichen Planus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Lichen Planus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Lichen Planus Market

• 24.1. USA Lichen Planus Market Overview
• 24.2. USA Lichen Planus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Lichen Planus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Lichen Planus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Lichen Planus Market

• 25.1. Canada Lichen Planus Market Overview
• 25.2. Canada Lichen Planus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Lichen Planus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Lichen Planus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Lichen Planus Market

• 26.1. South America Lichen Planus Market Overview
• 26.2. South America Lichen Planus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Lichen Planus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Lichen Planus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Lichen Planus Market

• 27.1. Brazil Lichen Planus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Lichen Planus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Lichen Planus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Lichen Planus Market

• 28.1. Middle East Lichen Planus Market Overview
• 28.2. Middle East Lichen Planus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Lichen Planus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Lichen Planus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Lichen Planus Market

• 29.1. Africa Lichen Planus Market Overview
• 29.2. Africa Lichen Planus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Lichen Planus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Lichen Planus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Lichen Planus Market Competitive Landscape And Company Profiles

• 30.1. Lichen Planus Market Competitive Landscape
• 30.2. Lichen Planus Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Merck & Co. Inc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Lichen Planus Market Other Major And Innovative Companies

• 31.1. Sanofi SA
• 31.2. Bristol-Myers Squibb Company
• 31.3. AstraZeneca plc
• 31.4. Novartis AG
• 31.5. GlaxoSmithKline plc
• 31.6. Takeda Pharmaceutical Company
• 31.7. Eli Lilly and Company
• 31.8. Teva Pharmaceutical Industries Ltd.
• 31.9. Boehringer Ingelheim International GmbH
• 31.10. Dr. Reddy's Laboratories Ltd
• 31.11. Amneal Pharmaceuticals Inc.
• 31.12. Hikma Pharmaceuticals plc
• 31.13. LEO Pharma A/S
• 31.14. Basilea Pharmaceutica Ltd.
• 31.15. UCB S.A.

32. Global Lichen Planus Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Lichen Planus Market

34. Recent Developments In The Lichen Planus Market

35. Lichen Planus Market High Potential Countries, Segments and Strategies

• 35.1 Lichen Planus Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Lichen Planus Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Lichen Planus Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer